# Bruno Lempernesse

> Bruno Lempernesse is the CEO of MDClone, an Israeli-founded healthcare data platform that lets organizations explore and share sensitive patient data using synthetic data that preserves privacy. A 25-year veteran of healthcare technology, data science, and life sciences, he joined MDClone as President of North America in September 2024 and stepped up to Chief Executive Officer in 2025. Before MDClone he was CEO of Carevive, a cancer-care and real-world-studies company acquired by Health Catalyst in 2024, and earlier spent two decades at Cegedim building its data and research business, plus leadership roles at SHYFT Analytics and Acorn AI (a Medidata company). He is an early pioneer of longitudinal patient data drawn from electronic medical records across Europe and the United States.

- **Role:** Chief Executive Officer at MDClone
- **Organizations:** MDClone, Carevive, SHYFT Analytics, Acorn AI (Medidata), Inflexxion, Cegedim
- **Education:** Master's, Marketing, Entrepreneurship & International Business, Novancia Business School Paris (Académie Commerciale Internationale)
- **Known for:** Grew and led Cegedim's Data and Research division over roughly two decades., Early pioneer in developing and using longitudinal patient data from electronic medical records across Europe and the US., As CEO of Carevive, expanded its digital cancer-care platform and real-world-studies business, culminating in acquisition by Health Catalyst in 2024.

## Career timeline

- **1990s-2010s** — Spent roughly 20 years at Cegedim building and leading its Data and Research division, including roles as General Manager USA & Canada and Global Chief Operating Officer.
- **2018-2020** — Senior Vice President and General Manager at SHYFT Analytics.
- **2020** — Led the commercial data solutions division at Acorn AI, a Medidata company.
- **2021** — Appointed CEO of Carevive Systems, a cancer-care technology and real-world-studies company.
- **2024** — Carevive acquired by Health Catalyst (May 2024).
- **2024** — Joined MDClone as President of North America (September 2024).
- **2025** — Named Chief Executive Officer of MDClone.

## Achievements

- Grew and led Cegedim's Data and Research division over roughly two decades.
- Early pioneer in developing and using longitudinal patient data from electronic medical records across Europe and the US.
- As CEO of Carevive, expanded its digital cancer-care platform and real-world-studies business, culminating in acquisition by Health Catalyst in 2024.
- Rose from President of North America to CEO of MDClone within about a year.

## Latest updates

- **2024-09** — Appointed President of North America at MDClone.
- **2025** — Named Chief Executive Officer of MDClone.

## Links

- Website: https://mdclone.com
- LinkedIn: https://www.linkedin.com/in/brunolempernesse/

---

Profile page: https://yespress.io/bruno-lempernesse
Published by YesPress — https://yespress.io
Last updated: 2026-07-22